Longitudinal Clinical Monitoring via Wearables
Background: The use of sensor-based movement analysis in clinical neurology is currently hindered by the scarcity of patient data, which restricts the development of robust, generalizable foundation models.
Question / Future Work: The transition from laboratory-based assessment to continuous, longitudinal real-world monitoring remains limited by the lack of personalized, clinically interpretable metrics that can account for inter-subject variability and track individual disease progression over time.
Why It Matters: Infrequent clinical rating scales are insensitive to subtle fluctuations; developing a longitudinal methodology for wearables is essential for clinical trial design and neurological patient management.
Evidence: Wearable digital biomarkers address the frequency problem, but population-level thresholds remain a blunt instrument for individual monitoring… prospective validation on longitudinal endpoints remains the subject of ongoing work.
Metadata & Links
- created_at
- 2026-04-23T05:48:57Z